Clinical-grade manufacturing of DC from CD14 + precursors: experience from phase I clinical trials in CML and malignant melanoma.

Autor:	Dietz, A. B.1, Padley, D. J.2, Butler, G. W.2, Maas, M. L.2, Greiner, C. W.2, Gastineau, D. A.3, Vuk-Pavlović, S1,3
Zdroj:	Cytotherapy (Taylor & Francis Ltd). Dec2004, Vol. 6 Issue 6, p563-570. 8p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect